BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

OriCell Advances First GPC3 CAR T Therapy Into Confirmatory Phase II Trial for Advanced Liver Cancer

OriCell Therapeutics Holdings Limited ( The "Company" or "Oricell") , announced that its proprietary GPC3-targeted autologous CAR-T therapy, Ori-C101,...

June 08, 2026 | News

Chime Biologics And Daewoong Pharmaceutical Partner To Advance Global Dupilumab Biosimilar Development

VMS Group is pleased to share that our portfolio company, Chime Biologics, in which we are also the controlling shareholder, has announced a strategic...

June 08, 2026 | News

Mabwell's First In Class Autoimmune Antibody 9MW5211 Wins China Clinical Trial Approval for IBD

Mabwell (688062.SH, 02493.HK), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announced that its independently...

June 08, 2026 | News

LongBio Pharma Debuts on Hong Kong Exchange With HK$10.7 Billion Valuation

LongBio Pharma, a portfolio company of Qiming Venture Partners and a leading innovative drug developer for allergic and autoimmune diseases in China, liste...

June 08, 2026 | News

Vcare PharmaTech Secures China Approval for Next Generation TRK Inhibitor Eratrectinib in NTRK Fusion Positive Solid Tumours

NTRK gene fusions have been identified as oncogenic drivers in adult and pediatric patients with pan-solid tumors. A fusion gene is typically formed by the...

June 08, 2026 | News

Innovent's Arcotatug Tavatecan Meets Phase 3 Endpoint in Advanced Gastric Cancer

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality me...

June 05, 2026 | News

DHCG And Altruist Biologics Partner To Accelerate Global Biologics Development Through China Manufacturing Expertise

Dark Horse Consulting Group (“DHCG” or “the Group”), a leader in strategic and operational biotherapeutics consulting, and Altruist...

June 05, 2026 | News

NOVI Health and Novo Nordisk Partner to Expand Access to Structured Medical Weight Care in Singapore

The collaboration aims to improve access to lifestyle coaching supported, clinically guided programs for patients exploring medical weight care. NOVI Heal...

June 04, 2026 | News

Travere Secures Global Rights to Civorebrutinib in $1.14 Billion Kidney Disease Partnership with Everest Medicines

Civorebrutinib is an investigational oral, covalent reversible BTK inhibitor designed to provide differentiated efficacy, safety and convenience in immun...

June 04, 2026 | News

Waters Introduces Cyclic IMS P20 to Advance Structural and Spatial Omics Research

Waters Corporation has introduced the Cyclic IMS P20 Mass Spectrometer, a next generation structural and spatial omics platform designed to provide researc...

June 04, 2026 | News

Samsung Epis Holdings Establishes First Global R&D Hub in Beijing to Advance ADC and Novel Drug Development

Establishes its first global research base as part of strategic new business expansion under the holding company structure Ÿ B...

June 03, 2026 | News

Scientific Infrastructure or Expensive Theatre? AI Discovery’s Reckoning in Asia

In October 2025, Eli Lilly announced it would build the most powerful supercomputer ever owned by a drug company. By February 2026, “LillyPod” ...

June 02, 2026 | Analysis

XtalPi Earns Second Milestone Payment As AI Drug Discovery Alliance With DoveTree Gains Momentum

XtalPi (2228.HK), an AI- and robotics- powered drug discovery platform, announced that its strategic collaboration with innovative biopharmaceutical c...

June 02, 2026 | News

Lilly Secures Global Rights To Hanmi's Sonefpeglutide In Potential $1.26 Billion Deal

Lilly licenses Hanmi's sonefpeglutide (LAPSGLP-2 analog) for multiple indications Hanmi Pharm. Co., Ltd. ("Hanmi") announced that they have entered i...

June 02, 2026 | News

Stay Connected